Related references
Note: Only part of the references are listed.The gut microbiome in atherosclerotic cardiovascular disease
Zhuye Jie et al.
NATURE COMMUNICATIONS (2017)
Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis
Angel Y. S. Wong et al.
DRUG SAFETY (2017)
Antibiotics promote inflammation through the translocation of native commensal colonic bacteria
Kathryn A. Knoop et al.
GUT (2016)
Statistical methods for studying disease subtype heterogeneity
Molin Wang et al.
STATISTICS IN MEDICINE (2016)
Diet, Lifestyle, Biomarkers, Genetic Factors, and Risk of Cardiovascular Disease in the Nurses' Health Studies
Edward Yu et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2016)
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Weifei Zhu et al.
CELL (2016)
Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial
Dorien Reijnders et al.
CELL METABOLISM (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
Association of macrolides with overall mortality and cardiac death among patients with various infections: A meta-analysis
Xiang Li et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2016)
Antibiotics as deep modulators of gut microbiota: between good and evil
Gianluca Ianiro et al.
GUT (2016)
Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011
Katherine E. Fleming-Dutra et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk The MESA Study
Peter J. Leary et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion
Franziska Faber et al.
NATURE (2016)
Interactions between the microbiota and pathogenic bacteria in the gut
Andreas J. Baumler et al.
NATURE (2016)
Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children
Katri Korpela et al.
NATURE COMMUNICATIONS (2016)
Cardiovascular outcomes associated with use of clarithromycin: population based study
Angel Y. S. Wong et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Cardiovascular outcomes associated with use of clarithromycin: population based study
Angel Y. S. Wong et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Azithromycin and Risk of Cardiovascular Death: A Meta-Analytic Review of Observational Studies
Aref A. Bin Abdulhak et al.
AMERICAN JOURNAL OF THERAPEUTICS (2015)
Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10 years in the CLARICOR randomised, blinded clinical trial
Per Winkel et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk
Yun-Jiu Cheng et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Risks of Cardiac Arrhythmia and Mortality Among Patients Using New-Generation Macrolides, Fluoroquinolones, and β-Lactam/β-Lactamase Inhibitors: A Taiwanese Nationwide Study
Hsu-Wen Chou et al.
CLINICAL INFECTIOUS DISEASES (2015)
Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia
Eric M. Mortensen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Antibiotics and the gut microbiota
Sheetal R. Modi et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Lack of Association between Azithromycin and Death from Cardiovascular Causes
Christine M. Khosropour et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study
Henrik Svanstrom et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Local proliferation dominates lesional macrophage accumulation in atherosclerosis
Clinton S. Robbins et al.
NATURE MEDICINE (2013)
Use of Azithromycin and Death from Cardiovascular Causes
Henrik Svanstrom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies
Stuart Schembri et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Use of Clarithromycin and Adverse Cardiovascular Events among Older Patients Receiving Donepezil: A Population-Based, Nested Case-Control Study
Janine R. Hutson et al.
DRUGS & AGING (2012)
Antibiotics in early life alter the murine colonic microbiome and adiposity
Ilseung Cho et al.
NATURE (2012)
Azithromycin and the Risk of Cardiovascular Death
Charles A. Knirsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Drug-induced QT interval prolongation: mechanisms and clinical management
Senthil Nachimuthu et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2012)
Azithromycin and the Risk of Cardiovascular Death
Wayne A. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
World Health Organization definition of myocardial infarction: 2008-09 revision
Shanthi Mendis et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2011)
Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study
Mette Charlot et al.
BRITISH MEDICAL JOURNAL (2011)
Long-term impacts of antibiotic exposure on the human intestinal microbiota
Cecilia Jernberg et al.
MICROBIOLOGY-SGM (2010)
Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota
Shigemitsu Tanaka et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2009)
A core gut microbiome in obese and lean twins
Peter J. Turnbaugh et al.
NATURE (2009)
Long-term ecological impacts of antibiotic administration on the human intestinal microbiota
Cecilia Jernberg et al.
ISME JOURNAL (2007)
Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Azithromycin for the secondary prevention of coronary events
JT Grayston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Oral erythromycin and the risk of sudden death from cardiac causes
WA Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Long-term persistence of resistant enterococcus species after antibiotics to eradicate Helicobacter pylori
M Sjölund et al.
ANNALS OF INTERNAL MEDICINE (2003)
Use of antibiotics is not associated with decreased risk of myocardial infarction among patients with diabetes
AJ Karter et al.
DIABETES CARE (2003)
Share Paper
